156 related articles for article (PubMed ID: 15190823)
1. [Effects of prostadyn sabale capsules on chronic prostatitis].
Wu T; Zhang X; Wu R; Liu X
Zhonghua Nan Ke Xue; 2004 May; 10(5):337-9. PubMed ID: 15190823
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary experience in treatment of chronic prostatitis/chronic pelvic pain syndrome with Longjintonglin capsule].
Shang XJ; Huang YF; Shao Y; Xue XT; Guan FG; Li G; Wang J
Zhonghua Nan Ke Xue; 2006 Apr; 12(4):371-3. PubMed ID: 16683576
[TBL] [Abstract][Full Text] [Related]
3. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
[TBL] [Abstract][Full Text] [Related]
4. [Clinical observation of Qanliexian decoction in the treatment of NIH III A prostatitis].
Huang J
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1044-6. PubMed ID: 18077920
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
[TBL] [Abstract][Full Text] [Related]
6. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis.
He L; Wang Y; Long Z; Jiang C
Urology; 2010 Mar; 75(3):654-7. PubMed ID: 19963254
[TBL] [Abstract][Full Text] [Related]
8. [Longqingpian combined with levofloxacin highly effective for type IIIA prostatitis].
Xu H; Shang XJ; Cai X; Teng WH; Huang YF
Zhonghua Nan Ke Xue; 2007 Apr; 13(4):338-41. PubMed ID: 17491269
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis].
Zeng X; Ye Z; Yang W; Liu J; Zhang X; Zhou X; Zhou S
Zhonghua Nan Ke Xue; 2004 Apr; 10(4):278-81. PubMed ID: 15148925
[TBL] [Abstract][Full Text] [Related]
10. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
[TBL] [Abstract][Full Text] [Related]
11. Chronic prostatitis during puberty.
Li Y; Qi L; Wen JG; Zu XB; Chen ZY
BJU Int; 2006 Oct; 98(4):818-21. PubMed ID: 16978277
[TBL] [Abstract][Full Text] [Related]
12. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
Nickel JC; Downey J; Ardern D; Clark J; Nickel K
J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of Prostat in the treatment of NIH category IIIA prostatitis].
Yan H; Liao Y; Gong B; Chen Z
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):930-1. PubMed ID: 15638027
[TBL] [Abstract][Full Text] [Related]
14. [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].
Lü M; Zhao ST; Wang SM; Shi BK; Fan YD; Wang JZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):169-72. PubMed ID: 15132876
[TBL] [Abstract][Full Text] [Related]
15. The prostate has secretory dysfunction for category IIIA and IIIB prostatitis.
Chen J; Zhao HF; Xu ZS
J Urol; 2007 Jun; 177(6):2166-9; discussion 2169. PubMed ID: 17509309
[TBL] [Abstract][Full Text] [Related]
16. Citrate in expressed prostatic secretions has the feasibility to be used as a useful indicator for the diagnosis of category IIIB prostatitis.
Chen J; Xu Z; Zhao H; Jiang X
Urol Int; 2007; 78(3):230-4. PubMed ID: 17406132
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of alpha1 adrenoceptor antagonist Naftopidil to the treatment of chronic non-bacterial prostatitis].
Li X; Li NC; Ding Q; Cai SL; Huo HX; Chen SY; Gu XJ; Chen SP; Na YQ
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):234-6, 239. PubMed ID: 16597040
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study of prostat combined with an antibiotic for chronic nonbacterial prostatitis].
Ye ZQ; Lan RZ; Wang SG; Cai SL; Chen GM; Li NC; Song Y; Na YQ
Zhonghua Nan Ke Xue; 2006 Sep; 12(9):807-10. PubMed ID: 17009533
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy and safety in the treatment of chronic abacterial prostatitis/chronic pelvic pain syndrome after intraprostatic injection of Chuanshentong].
Liu ZT; Liao HQ; Yang JY; Yang LY; Yang JR; Zhao XK; Liu R
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):705-7. PubMed ID: 16209215
[TBL] [Abstract][Full Text] [Related]
20. Combination regimen in the treatment of chronic prostatitis.
Chen WM; Yang CR; Ou YC; Ho HC; Su CK; Chiu KY; Cheng CL
Arch Androl; 2006; 52(2):117-21. PubMed ID: 16443588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
